Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Evaluating the impact of transpulmonary mechanical power on patients with severe ARDS on ECMO

Official title: Effect of Transpulmonary Mechanical Power on the Prognosis of Patients With Severe Acute Respiratory Distress Syndrome Treated With Venovenous Extracorporeal Membrane Oxygenation

Run by Beijing Chao Yang Hospital · NCT06062212 · Data updated 2026-11-12

This study is trying to see if measuring the power of breathing machines can help doctors predict how well patients with severe lung problems on ECMO will do and improve their treatment.

More Acute Respiratory Distress Syndrome trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment100 (estimated)
SponsorBeijing Chao Yang Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedDecember 30, 2027
Study endsApril 30, 2028
Registry record updatedNovember 5, 2026
Trial IDNCT06062212 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with severe ARDS who are currently receiving VV-ECMO support.

Probably not a fit

Patients who have been on high pressure ventilation for more than 7 days or have severe chronic lung disease with a life expectancy of less than 6 months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of transpulmonary mechanical power in predicting the prognosis of patients suffering from severe acute respiratory distress syndrome (ARDS) who are receiving venovenous extracorporeal membrane oxygenation (VV-ECMO). The study aims to understand how mechanical ventilation settings can affect patient outcomes and the potential for ventilator-related lung injury. By focusing on transpulmonary pressure, the research seeks to provide insights into optimizing treatment strategies for ARDS patients on ECMO. The findings could help improve the management of these critically ill patients.

Why it matters

Potential benefit: If successful, this study could lead to improved prognostic assessments and treatment strategies for patients with severe ARDS, potentially reducing mortality rates.

How similar studies have gone: While the specific approach of assessing transpulmonary mechanical power is novel, studies on mechanical ventilation and ECMO have shown varying degrees of success in improving patient outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Meet the diagnostic criteria of Berlin's definition for ARDS;
2. Receiving VV-ECMO support.

Exclusion Criteria:

1. Patients had been on high pressure (Ppeak \>35 cm H2O) and a high fraction of inspired oxygen (FiO2\>0.8) ventilation for \>7 days;
2. Patients had a contraindication to heparinization;
3. Patients had an irreversible neurological injury;
4. Patients had severe chronic lung disease with life expectancy \<6 months.

Where it's running

  • Beijing Chao-Yang Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.